Masakazu Haneda, Akizuki Morikawa. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Blood Glucose/metabolismDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyDiabetic Nephropathies/bloodDiabetic Nephropathies/complicationsDiabetic Nephropathies/drug therapyGlycated Hemoglobin A/metabolismHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/classificationHypoglycemic Agents/therapeutic useInsulin/therapeutic useKidney Failure, Chronic/bloodKidney Failure, Chronic/complicationsKidney Failure, Chronic/drug therapyRenal Insufficiency, Chronic/bloodRenal Insufficiency, Chronic/classificationRenal Insufficiency, Chronic/complicationsRenal Insufficiency, Chronic/drug therapy
Substances: See more » Blood GlucoseGlycated Hemoglobin AHypoglycemic AgentsInsulin
Year: 2008 PMID: 19015168 DOI: 10.1093/ndt/gfn616
Source DB: PubMed Journal: Nephrol Dial Transplant ISSN: 0931-0509 Impact factor: 5.992